Viewing Study NCT01080066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-01 @ 12:28 PM
Study NCT ID: NCT01080066
Status: COMPLETED
Last Update Posted: 2014-07-08
First Post: 2010-02-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Squamous Cell of Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carcinoma View
None Squamous cell View
None Erbitux View
None cetuximab View
None Head View
None Neck View